192 related articles for article (PubMed ID: 20179805)
1. Capecitabine-induced cardiotoxicity: case report and review of the literature.
Ang C; Kornbluth M; Thirlwell MP; Rajan RD
Curr Oncol; 2010 Feb; 17(1):59-63. PubMed ID: 20179805
[TBL] [Abstract][Full Text] [Related]
2. Managing 5FU Cardiotoxicity in Colorectal Cancer Treatment.
Anaka M; Abdel-Rahman O
Cancer Manag Res; 2022; 14():273-285. PubMed ID: 35115827
[TBL] [Abstract][Full Text] [Related]
3. Capecitabine induced cardiotoxicity: a case report and review of literature.
Tunio MA; Hashmi A; Shoaib M
Pak J Pharm Sci; 2012 Jan; 25(1):277-81. PubMed ID: 22186341
[TBL] [Abstract][Full Text] [Related]
4. Acute presentation of vasospastic angina induced by oral capecitabine: a case report.
Golias C; Dimitriadis G; Dimitriadis D; Graidis C; Dimitrelos I; Tsiakou A; Bitsis T; Charalabopoulos K
J Med Case Rep; 2014 Jan; 8():18. PubMed ID: 24428956
[TBL] [Abstract][Full Text] [Related]
5. Paradoxical effect of capecitabine in 5-fluorouracil-induced cardiotoxicity: A case vignette and literature review.
Saneeymehri SS; Markey KR; Mahipal A
J Oncol Pharm Pract; 2016 Jun; 22(3):552-5. PubMed ID: 25852107
[TBL] [Abstract][Full Text] [Related]
6. Capecitabine-induced coronary artery vasospasm in a patient who previously experienced a similar episode with fluorouracil therapy.
Karakulak UN; Aladağ E; Maharjan N; Övünç K
Turk Kardiyol Dern Ars; 2016 Jan; 44(1):71-4. PubMed ID: 26875134
[TBL] [Abstract][Full Text] [Related]
7. [Cardiotoxicity of continuous intravenous infusion of 5-fluorouracil: clinical study, prevention and physiopathology. Apropos of 13 cases].
de Forni M; Bugat R; Sorbette F; Delay M; Bachaud JM; Chevreau C
Bull Cancer; 1990; 77(5):429-38. PubMed ID: 2205312
[TBL] [Abstract][Full Text] [Related]
8. Capecitabine cardiotoxicity--case reports and literature review.
Manojlovic N; Babic D; Stojanovic S; Filipovic I; Radoje D
Hepatogastroenterology; 2008; 55(85):1249-56. PubMed ID: 18795667
[TBL] [Abstract][Full Text] [Related]
9. Capecitabine-mediated heart failure in colorectal cancer: a case series.
McAndrew EN; Jassal DS; Goldenberg BA; Kim CA
Eur Heart J Case Rep; 2021 Mar; 5(3):ytab079. PubMed ID: 33709051
[TBL] [Abstract][Full Text] [Related]
10. Capecitabine in breast cancer: the issue of cardiotoxicity during fluoropyrimidine treatment.
Molteni LP; Rampinelli I; Cergnul M; Scaglietti U; Paino AM; Noonan DM; Bucci EO; Gottardi O; Albini A
Breast J; 2010; 16 Suppl 1():S45-8. PubMed ID: 21050310
[TBL] [Abstract][Full Text] [Related]
11. Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: a systematic review of incidence, manifestations and predisposing factors.
Polk A; Vaage-Nilsen M; Vistisen K; Nielsen DL
Cancer Treat Rev; 2013 Dec; 39(8):974-84. PubMed ID: 23582737
[TBL] [Abstract][Full Text] [Related]
12. Capecitabine-Induced Coronary Vasospasm.
Henry D; Rudzik F; Butts A; Mathew A
Case Rep Oncol; 2016; 9(3):629-632. PubMed ID: 27920693
[TBL] [Abstract][Full Text] [Related]
13. Incidence and risk markers of 5-fluorouracil and capecitabine cardiotoxicity in patients with colorectal cancer.
Dyhl-Polk A; Vaage-Nilsen M; Schou M; Vistisen KK; Lund CM; Kümler T; Appel JM; Nielsen DL
Acta Oncol; 2020 Apr; 59(4):475-483. PubMed ID: 31931649
[No Abstract] [Full Text] [Related]
14. 5-Fluorouracil, capecitabine and vasospasm: a scoping review of pathogenesis, management options and future research considerations.
Teperikidis E; Boulmpou A; Charalampidis P; Tsavousoglou C; Giannakoulas G; Papadopoulos CE; Vassilikos V
Acta Cardiol; 2022 Feb; 77(1):1-13. PubMed ID: 33683181
[TBL] [Abstract][Full Text] [Related]
15. Fluoropyrimidine Cardiotoxicity: Time for a Contemporaneous Appraisal.
Upshaw JN; O'Neill A; Carver JR; Dimond EP; Denlinger CS; Kircher SM; Wagner LI; Ky B; Brell JM
Clin Colorectal Cancer; 2019 Mar; 18(1):44-51. PubMed ID: 30348619
[TBL] [Abstract][Full Text] [Related]
16. 5-fluorouracil cardiotoxicity is a rare, dose and schedule-dependent adverse event: a prospective study.
Tsavaris N; Kosmas C; Vadiaka M; Skopelitis E; Kopteridis P; Pamouki S; Efremidis M; Kasparian H; Moisakis I; Sakelariou D; Koufos C
J BUON; 2005; 10(2):205-11. PubMed ID: 17343330
[TBL] [Abstract][Full Text] [Related]
17. Is there a role for remote ischemic conditioning in preventing 5-fluorouracil-induced coronary vasospasm?
Chong J; Ho AF; Yap J; Bulluck H; Hausenloy DJ
Cond Med; 2019 Oct; 2(5):204-212. PubMed ID: 32133437
[TBL] [Abstract][Full Text] [Related]
18. Cardiotoxicity Induced by Capecitabine and Oxaliplatin in Gastric Cancer Treatment: A Rare Case of Cardiac Arrest and Cardiogenic Shock.
Gondal MUR; Lemoine J; Segal J; Kiyani Z; Bilal MI; Ansari F; McCauley B
Eur J Case Rep Intern Med; 2024; 11(4):004417. PubMed ID: 38584909
[TBL] [Abstract][Full Text] [Related]
19. Capecitabine induces both cardiomyopathy and multifocal cerebral leukoencephalopathy.
Endo A; Yoshida Y; Nakashima R; Takahashi N; Tanabe K
Int Heart J; 2013; 54(6):417-20. PubMed ID: 24309454
[TBL] [Abstract][Full Text] [Related]
20. Incidence and risk factors for capecitabine-induced symptomatic cardiotoxicity: a retrospective study of 452 consecutive patients with metastatic breast cancer.
Polk A; Shahmarvand N; Vistisen K; Vaage-Nilsen M; Larsen FO; Schou M; Nielsen DL
BMJ Open; 2016 Oct; 6(10):e012798. PubMed ID: 27798021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
